Latest Past Events

Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study


Lysogene will host a live webcast on Wednesday, November 23, 2022 at 1:30 pm CET to provide updates and topline results from the Phase 2/3 AAVance study evaluating LYS-SAF302, an investigational gene therapy for the treatment of MPS IIIA. Participants may register for the webcast by via the following website!/lysogene/20221123_1 Presentation is available here. […]

Lysogene COVID-19 update

Get In Touch

Don’t hesitate to contact us if you need more help.